Psychiatric Comorbidities in Women With Complete Androgen Insensitivity Syndrome or Müllerian Duct Aplasia/Agenesis
- PMID: 39391975
- PMCID: PMC12187188
- DOI: 10.1210/clinem/dgae720
Psychiatric Comorbidities in Women With Complete Androgen Insensitivity Syndrome or Müllerian Duct Aplasia/Agenesis
Abstract
Context: Understanding mental health issues facing individuals with disorders/differences of sex development (DSD) is crucial for optimizing evidence-based practices in this population.
Objectives: This work aimed to compare the prevalence of psychiatric diagnoses among patients diagnosed with complete androgen insensitivity syndrome (CAIS) or müllerian duct aplasia/agenesis (MA) to male and female reference groups.
Methods: A retrospective cohort study was conducted among 3 large integrated health systems. Participants included all individuals with confirmed CAIS or MA enrolled in 1 of 3 Kaiser Permanente health-care systems between January 1, 1988, and January 31, 2017. For each DSD patient, age-, race/ethnicity- and health system-matched male and female referents with typical sex development were randomly selected. Outcome measurements were mental health diagnoses and use of psychiatric medications.
Results: The prevalence of anxiety and depressive disorders in the CAIS and MA cohorts was approximately twice as high as in male referents without DSD, but the corresponding differences relative to female referents were less evident. A subgroup of MA patients with uterine agenesis had a higher prevalence of bipolar disorder than either reference group, but these results were accompanied by wide CIs. Women with CAIS and MA more frequently filled psychiatric medications compared to male but not female referents.
Conclusion: On balance, these findings are reassuring, albeit requiring confirmation in other settings. Future studies using longitudinal designs and patient-reported outcomes are needed to evaluate changes in mental health status of CAIS and MA patients at different ages and different intervals following initial diagnosis.
Keywords: MRKH; complete androgen insensitivity syndrome; differences of sex development; disorders of sex development; müllerian duct agenesis; psychiatric morbidity; vaginal agenesis.
© The Author(s) 2024. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com. See the journal About page for additional terms.
Comment in
-
Psychiatric Aspects of Differences of Sex Development: Uncertainty in Our Knowledge.J Clin Endocrinol Metab. 2025 Sep 16;110(10):e3526-e3527. doi: 10.1210/clinem/dgae811. J Clin Endocrinol Metab. 2025. PMID: 39560099 No abstract available.
References
-
- Lee PA, Houk CP, Ahmed SF, Hughes IA, International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society, the European Society for Paediatric Endocrinology . Consensus statement on management of intersex disorders. International consensus conference on intersex. Pediatrics. 2006;118(2):e488‐e500. - PubMed
-
- Hines M. Gonadal hormones and sexual differentiation of human brain and behavior. In: Pfaff DW, Joëls M, eds. Hormones, Brain and Behavior. Vol 5. 3rd ed. Academic Press; 2017:247‐278.
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
